Viewing Study NCT04440059


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-25 @ 1:00 PM
Study NCT ID: NCT04440059
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2020-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module